NATURAL AROMATASE INHIBITORS

  1. … hormonal treatment for vulvovaginal atrophy in women with estrogen receptor-positive breast cancer who are on adjuvant Aromatase inhibitor therapy: meta-analysis
  2. 11 Aromatase inhibitors
  3. 2 Recent Developments in Aromatase Inhibition as a Potential Treatment for Oestrogen-Dependent Breast Cancer
  4. 227 EFFECTS OF A SINGLE DOSE OF A NONSTEROIDAL Aromatase INHIBITOR ON OVARIAN FUNCTION IN CATTLE
  5. 4 EFFECT OF A PROLONGED Aromatase INHIBITOR TREATMENT ON PRE-OVULATORY OVARIAN FOLLICLES IN CATTLE
  6. A new class of nonsteroidal Aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes Aromatase and 17α …
  7. A novel activity for a group of sesquiterpene lactones: inhibition of Aromatase
  8. A pilot study comparing the effect of flaxseed, Aromatase inhibitor, and the combination on breast tumor biomarkers
  9. Activating mutations of ESR1, BRCA1 and CYP19 Aromatase genes confer tumor response in breast cancers treated with antiestrogens
  10. Advances in the stereoselective synthesis of antifungal agents and Aromatase inhibitors
  11. Anti-Aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus)
  12. Anti-Aromatase activity of the constituents from damiana (Turnera diffusa)
  13. Anti‐Aromatase Chemicals in Red Wine
  14. Aromatase activity in quail brain: correlation with aggressiveness
  15. Aromatase activity in the ovary and brain of the eastern mosquitofish (Gambusia holbrooki) exposed to paper mill effluent.
  16. Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids
  17. Aromatase inhibition by an 11, 13-dihydroderivative of a sesquiterpene lactone
  18. Aromatase inhibition by flavonoids
  19. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts—a comparative study
  20. Aromatase inhibition: determinants of response and resistance
  21. Aromatase inhibitor of formestane and letrozole on sexual differentiation of muscovy [J]
  22. Aromatase Inhibitor, Flax seed and Sage Effects on Adult Rats Fertility and Sexual Behavior
  23. Aromatase inhibitors and their potential clinical significance
  24. Aromatase inhibitors in Breast Cancer: The Discovery of New Compounds by Computational Design and Biochemical Evaluation
  25. Aromatase inhibitors in breast cancer: the discovery of new computational design and biochemical evaluation
  26. Aromatase inhibitors in cigarette smoke, tobacco leaves and other plants
  27. Aromatase inhibitors in the treatment of breast cancer
  28. Aromatase inhibitors: a new paradigm in breast cancer treatment
  29. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer
  30. Aromatase inhibitors: past, present and future
  31. Aromatase inhibitors: rationale and use in breast cancer
  32. Aromatase inhibitors: structural features and biochemical characterization
  33. Aromatase inhibitory activity of geranylated coumarins, mammeasins C and D, isolated from the flowers of Mammea siamensis
  34. Aromatase inhibitory, radical scavenging, and antioxidant activities of depsidones and diaryl ethers from the endophytic fungus Corynespora cassiicola L36
  35. Aromatase modulation alters gonadal differentiation in developing zebrafish (Danio rerio)
  36. Aromatase, 3β-HYDROXYSTEROID DEHYDROGENASE Δ5/Δ4 ISOMERASE AND 17β-HYDROXYSTEROID DEHYDROGENASE INHIBITION BY …
  37. Aromatase, Aromatase inhibitors, and breast cancer
  38. Aromatase: contributions to physiology and disease in women and men
  39. Assessing effects of Aromatase inhibition on fishes with group-synchronous oocyte development using western mosquitofish (Gambusia affinis) as a model
  40. Assessment of chemical effects on Aromatase activity using the H295R cell line
  41. Assessment of the Aromatase Inhibitory Activity of Ma-Huang-Tang (MHT) and Its Active Compounds
  42. Bis (4-hydroxy-2H-chromen-2-one) coumarin induces apoptosis in MCF-7 human breast cancer cells through Aromatase inhibition
  43. Brain Aromatase: roles in reproduction and neuroprotection
  44. Cactus flower extracts may prove beneficial in benign prostatic hyperplasia due to inhibition of 5α reductase activity, Aromatase activity and lipid peroxidation
  45. Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity
  46. Chalcones are potent inhibitors of Aromatase and 17β-hydroxysteroid dehydrogenase activities
  47. Changes of breast cancer growth and metastasis in murine models modulated by an Aromatase inhibitor, a low calcium diet or a high fat diet
  48. Characterization of Aromatase binding agents from the dichloromethane extract of Corydalis yanhusuo using ultrafiltration and liquid chromatography tandem mass …
  49. Chemical Constituents from Artemisia annua and Vitex agnus-castus as New Aromatase inhibitors: In-vitro and In-silico Studies
  50. Chemoendocrine metronomic therapy of estrogen receptor-positive breast cancer by taxanes or capecitabine in combination with Aromatase inhibitors
  51. Chrysin: is it an effective Aromatase inhibitor
  52. Clinical and Genetic Predictors of Aromatase Inhibitor-Induced Arthralgia
  53. Coadministrating luteolin minimizes the side effects of the Aromatase inhibitor letrozole
  54. Coadministration of the Aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma
  55. Comparison of the effects of nobiletin and letrozole on the activity and expression of Aromatase in the MCF-7 breast cancer cell line
  56. Comprehensive and automated linear interaction energy based binding-affinity prediction for multifarious cytochrome P450 Aromatase inhibitors
  57. Computational investigations of cytochrome P450 Aromatase catalysis and biological evaluation of isoflavone Aromatase inhibitors
  58. Computational methods for the design of potent Aromatase inhibitors
  59. Correlation of rs749292 and rs700518 polymorphisms in the Aromatase gene (CYP19A1) with osteoporosis in postmenopausal Polish women
  60. Currently used pesticides and their mixtures affect the function of sex hormone receptors and Aromatase enzyme activity
  61. De novo designing, assessment of target affinity and binding interactions against Aromatase: Discovery of novel leads as anti-breast cancer agents
  62. Depsidones inhibit Aromatase activity and tumor cell proliferation in a co-culture of human primary breast adipose fibroblasts and T47D breast tumor cells
  63. Design, synthesis and activity of flavonoids Aromatase inhibitors
  64. Design, synthesis, and 3D QSAR of novel potent and selective Aromatase inhibitors
  65. Development of an LC-MS/MS method for Aromatase inhibitor screening
  66. Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF‐7 cells overexpressing Aromatase
  67. Disruption of Aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review
  68. Distribution of Aromatase activity in brain and peripheral tissues of male sheep: effect of nutrition
  69. Diverse functions of Aromatase: O-deethylation of 7-ethoxycoumarin
  70. DNA methylation of the gonadal Aromatase (cyp19a) promoter is involved in temperature-dependent sex ratio shifts in the European sea bass
  71. Drugs used for ovarian stimulation: Clomiphene citrate, Aromatase inhibitors, metformin, gonadotropins, gonadotropin-releasing hormone analogs, and recombinant …
  72. Effect of Aromatase inhibitors on the ovarian development of stunted yearlings of rohu (Labeo rohita): a preliminary study
  73. Effect of Buthus martensi Karsch on Aromatase Activity and Cytokine-Inducded NOS and NO Production in Osteoblasts and Leukaemic Cell Line FLG 29.1
  74. Effect of Genistein and 2, 3, 7, 8-tetrachlorodibenzo_; 7a/^ a-TCDD On Aromatase Activity
  75. Effect of Hop (Humulus lupulus L.) Flavonoids on Aromatase (Estrogen Synthase) Activity
  76. Effect of the application of Aromatase inhibitors on sex reversal and zootechnical performance of broiler chicken.
  77. Effective anti-Aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal Aromatase inhibitors
  78. Effects of a non-steroidal Aromatase inhibitor on ovarian function in cattle
  79. Effects of atrazine on CYP19 gene expression and Aromatase activity in testes and on plasma sex steroid concentrations of male African clawed frogs (Xenopus laevis …
  80. Effects of atrazine on metamorphosis, growth, laryngeal and gonadal development, Aromatase activity, and sex steroid concentrations in Xenopus laevis
  81. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and Aromatase activity in vitro
  82. Effects of exposure to oestrogenic compounds on Aromatase gene expression are gender dependent in the rainbowfish, Melanotaenia fluviatilis
  83. Effects of Isoflavones on Estrogen Receptor Mediated Estrogenicity and Aromatase Activity
  84. Effects of lactone derivatives on Aromatase (CYP19) activity in H295R human adrenocortical and (anti) androgenicity in transfected LNCaP human prostate cancer …
  85. Effects of maternal exposure to an Aromatase inhibitor on sexual behaviour and neurochemical and endocrine aspects of adult male rat
  86. Effects of neonicotinoids on promoter-specific expression and activity of Aromatase (CYP19) in human adrenocortical carcinoma (H295R) and primary umbilical vein …
  87. Effects of nutrition relevant mixtures of phytoestrogens on steroidogenesis, Aromatase, estrogen, and androgen activity
  88. Effects of Ovarian Development by P450 Aromatase Activity Controled in Mice [J]
  89. Effects of phytoestrogens on Aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells
  90. Effects of the Aromatase inhibitor fadrozole on gene expression in the zebrafish brain
  91. Efficacy of cactus flowers miller treatment in benign prostatic hyperplasia due to inhibition of 5α reductase activity, Aromatase activity and lipid peroxidation.
  92. Efficacy of management strategies for Aromatase inhibitor‐induced arthralgia in breast cancer patients: a systematic review
  93. Egonol gentiobioside and egonol gentiotrioside from Styrax perkinsiae promote the biosynthesis of estrogen by Aromatase
  94. Emerging Chemicals Targeting Aromatase: Protective Compounds or Endocrine Disruptors?
  95. Enhanced Expression of Aromatase in Tamoxifen Resistant Human Breast Cancer
  96. Enzymatic control of estrogen production in human breast cancer: relative significance of Aromatase versus sulfatase pathways
  97. Ergostane-type sterols from king trumpet mushroom (Pleurotus eryngii) and their inhibitory effects on Aromatase
  98. Eurycomanone, the major quassinoid in Eurycoma longifolia root extract increases spermatogenesis by inhibiting the activity of phosphodiesterase and Aromatase in …
  99. Evaluation of a 40 day assay for testing endocrine disrupters: effects of an anti-estrogen and an Aromatase inhibitor on sex ratio and vitellogenin concentrations in …
  100. Evaluation of Synthesized Ester or Amide Coumarin Derivatives on Aromatase Inhibitory Activity
  101. Evaluation of the Aromatase Inhibitor Fadrozole in a Short-Term Reproduction Assay with the Fathead Minnow (Pimephales promelas)
  102. Evaluation of the biochemical activity of new modified steroids as Aromatase inhibitors
  103. Evaluation of the biochemical activity of new modified steroids as Aromatase inhibitors
  104. Evaluation of ursolic acid isolated from Ilex paraguariensis and derivatives on Aromatase inhibition
  105. Everolimus downregulates estrogen receptor and induces autophagy in Aromatase inhibitor-resistant breast cancer cells
  106. Extraction, isolation, and Aromatase inhibitory evaluation of low-polar ginsenosides from Panax ginseng leaves
  107. Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of Aromatase for the treatment of estrogen-dependent disease
  108. Fetal safety profile of Aromatase inhibitors: Animal data
  109. Flavans from Desmos cochinchinensis as potent Aromatase inhibitors
  110. Flavonoid inhibition of Aromatase enzyme activity in human preadipocytes
  111. GBEs as an Aromatase Inhibitor for Hormone Adjuvant Therapy
  112. Genistein induces breast cancer-associated Aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model
  113. Growth inhibitory efficacy and anti‑Aromatase activity of Tabebuia avellanedae in a model for post‑menopausal Luminal A breast cancer
  114. Hexanol Extracts of Cyperus Rotundus Inhibited Aromatase Activity in JEG-3 Cells
  115. HUMAN Aromatase GENE EXPRESSION IN ADIPOSE TISSUE
  116. Hypothalamic–pituitary–gonadal axis in two men with Aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the …
  117. Icariin from Epimedium brevicornum Maxim promotes the biosynthesis of estrogen by Aromatase (CYP19)
  118. Identification of endocrine disrupting chemicals acting on human Aromatase
  119. Impairment of spermatogenesis in mice lacking a functional Aromatase (cyp 19) gene
  120. In silico Docking Approach of Coumarin Derivatives as an Aromatase Antagonist
  121. Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with Aromatase inhibitors
  122. Increased sperm cell production in ageing roosters by an oral treatment with an Aromatase inhibitor and a natural herbal extract designed for improving fertility
  123. Induction and inhibition of Aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells
  124. Inhibition of Aromatase and cell proliferation of breast cancer and human placenta choriocarcinoma by Prunus persica extracts
  125. Inhibition of Aromatase and α-Amylase by Flavonoids and Proanthocyanidins from Sorghum bicolor Bran Extracts
  126. Inhibitory Aromatase effects of flavonoids from Ginkgo biloba extracts on estrogen biosynthesis
  127. Inhibitory effect of chrysin on estrogen biosynthesis by suppression of enzyme Aromatase (CYP19): A systematic review
  128. Inhibitory effect of luteolin on estrogen biosynthesis in human ovarian granulosa cells by suppression of Aromatase (CYP19)
  129. Inhibitory effect of Sphagnum palustre extract and its bioactive compounds on Aromatase activity
  130. Inhibitory effects of Ginkgo biloba extract on Aromatase activity and tumor suppression in Aromatase xenograft model
  131. Integrated in silico-in vitro strategy for screening of some traditional Egyptian plants for human Aromatase inhibitors
  132. Interference of endocrine disrupting chemicals with Aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish
  133. Interrelationships between Aromatase and cyclooxygenase-2 and their role in the autocrine and paracrine mechanisms in breast cancer
  134. Investigating the Effects of Aromatase inhibitors on the Musculoskeletal System
  135. Lead molecules as novel Aromatase inhibitors: in silico de novo designing and binding affinity studies
  136. Levels of Aromatase and Estrogen Receptors mRNA in Early Larvae of Alburnus tarichi (Güldenstӓdt, 1814) Exposed to Di-(2-ethylhexyl)-phthalate
  137. Luteolin-7-methylether from Leonurus japonicus inhibits estrogen biosynthesis in human ovarian granulosa cells by suppression of Aromatase (CYP19)
  138. Mammalian lignans and genistein decrease the activities of Aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cells
  139. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant Aromatase inhibitor therapy
  140. Mechanism and inhibition of cytochrome P-450 Aromatase
  141. Modulation of Aromatase activity as a mode of action for endocrine disrupting chemicals in a marine fish
  142. Modulation of Aromatase by natural compounds—A pharmacophore guided molecular modelling simulations
  143. Modulation of Aromatase by phytoestrogens
  144. Molecular basis for the interaction of four different classes of substrates and inhibitors with human Aromatase
  145. Molecular cloning and developmental expression of Aromatases gene in two species of loaches
  146. Molecular docking studies on borapetol with target Aromatase related to breast cancer
  147. Molecular Modelling of Estrogen-Producing Enzymes CYP450 Aromatase and 17beta-Hydroxysteroid Dehydrogenase Type 1
  148. Molecular pharmacology of Aromatase and its regulation by endogenous and exogenous agents
  149. Musculoskeletal side effects of Aromatase inhibitors treatment in women with breast cancer
  150. natural product compounds with Aromatase inhibitory activity: an update
  151. natural products as Aromatase inhibitors: Identification and structure-activity aspects
  152. Nelumal A, the Active Principle of Ligularia nelumbifolia, is a Novel Aromatase Inhibitor
  153. New 7, 8-benzoflavanones as potent Aromatase inhibitors: synthesis and biological evaluation
  154. No evidence for the in vivo activity of Aromatase-inhibiting flavonoids
  155. No indications of socially induced changes in brain Aromatase activity in guppy (Poecilia reticulata) males
  156. Nonsteroidal Aromatase inhibitors for the treatment of breast cancer: an update
  157. Nonsteroidal Aromatase inhibitors: recent advances
  158. Novel inhibitor discovery against Aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug design
  159. Novel irreversible Aromatase inhibitors
  160. Nutrigenomics-associated impacts of nutrients on genes and enzymes with special consideration of Aromatase
  161. Optimization of the Aromatase inhibitory activities of pyridylthiazole analogues of resveratrol
  162. Origin of Aromatase inhibitory activity via proteochemometric modeling
  163. P450 Aromatase alterations and DNA damage as avian pollution biomarkers in cliff and cave swallow breeding near the Rio Grande region, Texas
  164. Pattern of Aromatase mRNA expression in the brain of a weakly electric fish, Apteronotus leptorhynchus
  165. Pharmacophore mapping of flavone derivatives for Aromatase inhibition
  166. Phytochemicals for breast cancer prevention by targeting Aromatase
  167. Phytoestrogens inhibit Aromatase but not 17β‐hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa‐luteal cells: evidence for FSH induction of 17β‐HSD
  168. PLACENTAL Aromatase ASSAY VALIDATION STUDY: POSITIVE CONTROL STUDY
  169. Potential effect of Olea europea leaves, Sonchus oleraceus leaves and Mangifera indica peel extracts on Aromatase activity in human placental microsomes and …
  170. Potential effects of environmental contaminants on P450 Aromatase activity and DNA damage in swallows from the Rio Grande and Somerville, Texas
  171. Potential utility of natural products as regulators of breast cancer-associated Aromatase promoters
  172. PRE-VALIDATION STUDY PLAN AND STUDY PROTOCOL FOR THE Aromatase ASSAY USING HUMAN, BOVINE, AND PORCINE PLACENTA, AND …
  173. Probing the origins of Aromatase inhibitory activity of disubstituted coumarins via QSAR and molecular docking
  174. Probing the xeno-oestrogenic impact of sediment cores contaminated by the pulp and paper industry: induction of Aromatase cyp19a1b in late larval zebrafish
  175. Prostaglandin E2-9-Ketoreductase and Prostaglandin F2α Activate Brain Aromatase to Induce Courtship in the Male Crested Newt, Triturus carnifex
  176. QSAR modeling of Aromatase inhibitory activity of 1-substituted 1, 2, 3-triazole analogs of letrozole
  177. QSAR study of diarylalkylimidazole and diarylalkyltriazole Aromatase inhibitors
  178. Quillaja saponins inhibit tilapia Aromatase activity in vitro
  179. Randomized, double-blind, placebo-controlled phase ii clinical trial on the use of uncaria tomentosa (Cat’s claw) for Aromatase inhibitor-induced arthralgia: A pilot …
  180. Recent advancement in nonsteroidal Aromatase inhibitors for treatment of estrogen-dependent breast cancer
  181. Recent Studies on Aromatase and Sulfatase Involved in Breast Cancer and their inhibitors
  182. Refinement of an OECD test guideline for evaluating the effects of endocrine disrupting chemicals on Aromatase gene expression and reproduction using novel …
  183. Regulation of Aromatase expression in breast cancer tissue
  184. Role of EGB 761 as a Possible Aromatase Inhibitor for Breast Cancer Therapy
  185. Role of estrogen receptors and Aromatase on brain protein synthesis rates in ovariectomized female rats fed genistein
  186. Screening for Aromatase ligands in the extract of Broussonetia papyrifera using high performance liquid chromatography and ESI-mass spectrometry
  187. Screening of herbal constituents for Aromatase inhibitory activity
  188. Selection of Appropriate Inhibitor for Ovarian Type Cytochrome P450 Aromatase Gene of Heteropneustesfossilis with the Application of Homology Modeling …
  189. Selective Inhibition of Aromatase by a Dihydroisocoumarin from Xyris pterygoblephara
  190. Sensitivity of New Zealand mudsnail Potamopyrgus antipodarum (Gray) to a specific Aromatase inhibitor
  191. Sex reversal of the amphibian, Xenopus tropicalis, following larval exposure to an Aromatase inhibitor
  192. Steroid and growth factor modulation of Aromatase activity in MCF7 and T47D breast carcinoma cell lines
  193. Steroidal alkaloids efficient Aromatase inhibitors with potential for the treatment of postmenopausal breast cancer
  194. Structure–function studies of Aromatase and its inhibitors: a progress report
  195. Superiority of Aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: hyaluronate-targeted versus PEGylated protamine nanocapsules for breast …
  196. Suppression of Aromatase (estrogen synthetase) by red wine phytochemicals
  197. Suppression of Aromatase activity in populations of bream (Abramis brama) from the river Elbe, Germany
  198. Synthesis and Aromatase inhibition properties of new boronic acid chalcone derivatives
  199. Synthesis and Aromatase inhibitory activity of novel pyridine-containing isoflavones
  200. Synthesis and biological evaluation of (±)-abyssinone II and its analogues as Aromatase inhibitors for chemoprevention of breast cancer
  201. Synthesis of Aromatase inhibitors and quinone reductase inducers for cancer chemoprevention studies
  202. Synthesis of casimiroin and optimization of its quinone reductase 2 and Aromatase inhibitory activities
  203. Synthesis of dl-standishinal and its related compounds for the studies on structure–activity relationship of inhibitory activity against Aromatase
  204. Synthesis of enterolactone and enterodiol precursors as potential inhibitors of human estrogen synthetase (Aromatase)
  205. Synthetic isoflavones and doping: A novel class of Aromatase inhibitors?
  206. Tebuconazole Disrupted Aromatase Activity and Reduced 17β-Estradiol Concentration in Pubertal Developmental Rats
  207. Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by Aromatase in endothelial cells: implications in atherosclerosis
  208. Thalassosterol, a new cytotoxic Aromatase inhibitor ergosterol derivative from the Red Sea seagrass Thalassodendron ciliatum
  209. The citrus flavonone hesperetin inhibits growth of Aromatase-expressing MCF-7 tumor in ovariectomized athymic mice
  210. The combined effects of temperature and Aromatase inhibitor on metamorphosis, growth, locomotion, and sex ratio of tiger frog (Hoplobatrachus rugulosus) …
  211. The Effect of in ovo Injection of Aromatase inhibitors on the Performance of Broilers
  212. The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of Aromatase in breast cancer cells
  213. The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of Aromatase gene expression
  214. The phenotype of the Aromatase knockout mouse reveals dietary phytoestrogens impact significantly on testis function
  215. The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing Aromatase
  216. The red wine polyphenol resveratrol displays bilevel inhibition on Aromatase in breast cancer cells
  217. The roles of sex steroids and their receptors in the regulation of brain Aromatase expression
  218. The use of Aromatase inhibitors in boys with short stature: what to know before prescribing?
  219. The use of the Klopman index as a new descriptor for pharmacophore analysis on strong Aromatase inhibitor flavonoids against estrogen-dependent breast cancer
  220. Total syntheses of the Aromatase inhibitors, mammeasins C and D, from Thai medicinal plant Mammea siamensis
  221. Total synthesis of the Aromatase inhibitor dihydroisocoumarin via protective opening of lactones
  222. Towards understanding Aromatase inhibitory activity via QSAR modeling
  223. White button mushroom phytochemicals inhibit Aromatase activity and breast cancer cell proliferation
  224. α-Glucosidase inhibitory, Aromatase inhibitory, and antiplasmodial activities of a biflavonoid GB1 from Garcinia kola stem bark
Shopping Cart
Scroll to Top